Compare WFG & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WFG | TMDX |
|---|---|---|
| Founded | 1955 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.6B |
| IPO Year | 2007 | 2019 |
| Metric | WFG | TMDX |
|---|---|---|
| Price | $63.50 | $121.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $89.50 | ★ $154.00 |
| AVG Volume (30 Days) | 205.8K | ★ 791.1K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 4.87 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $5.36 | $24.12 |
| Revenue Next Year | $10.63 | $18.69 |
| P/E Ratio | ★ N/A | $26.48 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $57.34 | $62.42 |
| 52 Week High | $79.22 | $156.00 |
| Indicator | WFG | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 32.99 | 36.81 |
| Support Level | $62.81 | $106.27 |
| Resistance Level | $76.61 | $128.96 |
| Average True Range (ATR) | 1.84 | 8.92 |
| MACD | -0.41 | -1.90 |
| Stochastic Oscillator | 12.37 | 0.30 |
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the Southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is one of the largest oriented strand board producers in the world.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.